The global Veterinary Diagnostics Market, which was valued at US$3.42 billion in 2024, has seen steady growth, reaching US$3.68 billion in 2025. Projections indicate a strong compound annual growth rate (CAGR) of 7.8% from 2025 to 2030, with an anticipated valuation of US$5.36 billion by the end of this period. This expansion is primarily attributed to notable technological advancements like point-of-care testing devices, molecular diagnostics such as PCR and LAMP, and AI-driven analysis tools. These innovations have not only enhanced the accuracy and speed of diagnostics but have also made them more accessible. Notably, the demand for diagnostics related to diabetes, kidney disorders, and infectious diseases in companion animals is on the rise, fueled by the increasing prevalence of zoonotic diseases.
The veterinary diagnostics market is segmented by animal type into companion animals and livestock, with the former dominating the market share in 2024. The surge in companion animal ownership, especially of pets like dogs and cats, is a key driver for this segment’s growth. Moreover, the growing awareness regarding pet health and the willingness of pet owners to invest in healthcare further propel the demand for advanced diagnostic tests and treatment options. Regarding end users, the market is categorized into veterinary reference laboratories, veterinary hospitals & clinics, POC/in-house testing, and veterinary research institutes & universities. The POC/in-house testing segment is expected to exhibit the highest CAGR during the forecast period, driven by the need for improved patient care, cost control, and the transition of diagnostic tests from clinical laboratories to near-patient settings.
Geographically, the Asia Pacific region is projected to be the fastest-growing market segment, owing to factors such as rapid urbanization, increasing pet adoption rates, and heightened awareness regarding animal health. Countries like China and India, with rising disposable incomes, are likely to witness higher spending on companion animal care. Additionally, government initiatives in the region aimed at strengthening livestock disease surveillance and control programs contribute to market growth. The expansion of veterinary infrastructure, the penetration of multinational diagnostic companies, and growing investments in animal health research and development are further propelling the market in the Asia Pacific region.
Key Players in the veterinary diagnostics market include IDEXX Laboratories, Zoetis Services LLC, Thermo Fisher Scientific Inc., Antech Diagnostics, and bioMérieux, among others. These companies are at the forefront of innovation, offering a range of diagnostic solutions for both companion animals and livestock. IDEXX Laboratories, for instance, is known for its in-clinic analyzers and cloud-based platforms that provide real-time diagnostic insights. Zoetis specializes in point-of-care instruments and AI-driven diagnostics, while Thermo Fisher Scientific focuses on molecular diagnostics and high-throughput platforms for disease detection in various animal species.
Key Takeaways:
– The veterinary diagnostics market is forecasted to grow at a CAGR of 7.8% from 2025 to 2030, reaching a valuation of US$5.36 billion.
– Technological advancements such as molecular diagnostics and AI-driven tools are driving the market’s expansion, offering accurate and accessible diagnostic solutions.
– The Asia Pacific region is expected to be the fastest-growing market segment, supported by factors like urbanization, pet adoption rates, and government initiatives.
– Leading companies like IDEXX Laboratories, Zoetis Services LLC, and Thermo Fisher Scientific are actively involved in developing innovative diagnostic solutions to meet the evolving needs of the market.
Read more on prnewswire.co.uk